Drug resistance of CLL cells is partly mediated by the expression of anti-apoptotic proteins BCL-XL and MCL-1, which are upregulated in vivo in lymph nodes [34,45] and by 3T40L stimulation in vitro [35]. The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.